Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration. | Aging (Albany NY) | 2022 | 35859293 | PubTator, text mining | PubMed |
| Protein expression profiling identifies a prognostic model for ovarian cancer. | BMC Womens Health | 2022 | 35840928 | PubTator, text mining | PubMed |
| Multi-target mechanisms against coronaviruses of constituents from Chinese Dagang Tea revealed by experimental and docking studies. | J Ethnopharmacol | 2022 | 35835344 | PubTator, text mining | PubMed |
| N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM). | Biomed Res Int | 2022 | 35813230 | PubTator, text mining | PubMed |
| Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal. | BMC Cancer | 2022 | 35810271 | PubTator, text mining | PubMed |
| miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium. | Int J Mol Sci | 2022 | 35805966 | PubTator, text mining | PubMed |
| Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion. | Cancers (Basel) | 2022 | 35804898 | PubTator, text mining | PubMed |
| Abstracts from "Chronic viral infection and cancer, openings for vaccines" virtual symposium of the TechVac network. | Infect Agent Cancer | 2022 | 35804458 | PubTator, text mining | PubMed |
| Calpain-mediated cleavage generates a ZBTB18 N-terminal product that regulates HIF1A signaling and glioblastoma metabolism. | iScience | 2022 | 35800763 | PubTator, text mining | PubMed |
| Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients. | Front Oncol | 2022 | 35795037 | PubTator, text mining | PubMed |
| Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review. | J Genet Eng Biotechnol | 2022 | 35792966 | PubTator, text mining | PubMed |
| An integrated atlas of human placental development delineates essential regulators of trophoblast stem cells. | Development | 2022 | 35792865 | PubTator, text mining | PubMed |
| LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p. | BMC Cancer | 2022 | 35787258 | PubTator, text mining | PubMed |
| TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | EMBO Rep | 2022 | 35785414 | PubTator, text mining | PubMed |
| Revisiting the Tenascins: Exploitable as Cancer Targets? | Front Oncol | 2022 | 35785162 | PubTator, text mining | PubMed |
| Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis. | Pathol Oncol Res | 2022 | 35783358 | PubTator, text mining | PubMed |
| Exploring the Relationship Between Senescence and Colorectal Cancer in Prognosis, Immunity, and Treatment. | Front Genet | 2022 | 35783270 | PubTator, text mining | PubMed |
| Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35774505 | PubTator, text mining | PubMed |
| Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. | J Exp Clin Cancer Res | 2022 | 35773731 | PubTator, text mining | PubMed |
| The close interaction between hypoxia-related proteins and metastasis in pancarcinomas. | Sci Rep | 2022 | 35773405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=34